Quris
Tel Aviv
About Quris
Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications. The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharma companies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing. Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $37.0M
- Funding stage: Seed
- Last round: Seed (Dec 2022)
- Website: quris.ai
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Pharmaceutical, Robotics
Social Profiles
Canonical: https://fsome.com/organization/quris-52979 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.